Thrivent Financial for Lutherans Lowers Holdings in Innospec Inc. $IOSP

Thrivent Financial for Lutherans reduced its position in shares of Innospec Inc. (NASDAQ:IOSP) by 49.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,915 shares of the specialty chemicals company’s stock after selling 17,842 shares during the period. Thrivent Financial for Lutherans owned approximately 0.07% of Innospec worth $1,382,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Baird Financial Group Inc. boosted its stake in Innospec by 11.5% during the first quarter. Baird Financial Group Inc. now owns 2,170 shares of the specialty chemicals company’s stock valued at $206,000 after buying an additional 223 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Innospec by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,833 shares of the specialty chemicals company’s stock valued at $1,405,000 after acquiring an additional 645 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Innospec by 8,176.5% in the 1st quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock valued at $16,147,000 after acquiring an additional 168,355 shares in the last quarter. NewEdge Advisors LLC boosted its position in shares of Innospec by 37.4% during the 1st quarter. NewEdge Advisors LLC now owns 4,567 shares of the specialty chemicals company’s stock valued at $433,000 after acquiring an additional 1,243 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Innospec by 6.4% during the first quarter. Goldman Sachs Group Inc. now owns 132,399 shares of the specialty chemicals company’s stock worth $12,545,000 after purchasing an additional 8,014 shares in the last quarter. Institutional investors own 96.64% of the company’s stock.

Innospec Stock Performance

Shares of IOSP opened at $86.58 on Friday. Innospec Inc. has a fifty-two week low of $70.10 and a fifty-two week high of $112.74. The firm has a market cap of $2.15 billion, a price-to-earnings ratio of -2,886.00 and a beta of 0.91. The firm has a 50 day moving average price of $80.42 and a 200-day moving average price of $79.16.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Zacks Research raised shares of Innospec from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 6th. Wall Street Zen raised shares of Innospec from a “hold” rating to a “buy” rating in a report on Saturday, December 13th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Innospec in a report on Monday, December 22nd. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Reduce”.

About Innospec

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.